These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7437223)

  • 41. Dantrolene dose response in awake man: implications for management of malignant hyperthermia.
    Flewellen EH; Nelson TE; Jones WP; Arens JF; Wagner DL
    Anesthesiology; 1983 Oct; 59(4):275-80. PubMed ID: 6614536
    [No Abstract]   [Full Text] [Related]  

  • 42. [A case of malignant hyperthermia in operative obstetrics].
    Kiwitt A; Pingel E
    Zentralbl Gynakol; 1985; 107(15):966-9. PubMed ID: 4050188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experimental malignant hyperthermia].
    Mayzner-Zawadzka E
    Pol Tyg Lek; 1980 Dec; 35(52):2073-76. PubMed ID: 7027208
    [No Abstract]   [Full Text] [Related]  

  • 44. Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia.
    Flewellen EH; Nelson TE
    Anesthesiology; 1984 Oct; 61(4):477. PubMed ID: 6486512
    [No Abstract]   [Full Text] [Related]  

  • 45. Malignant hyperthermia.
    Willner J
    Pediatr Ann; 1984 Feb; 13(2):128, 130, 132-4. PubMed ID: 6369232
    [No Abstract]   [Full Text] [Related]  

  • 46. Malignant hyperthermia. Dantrolene--dynamics and kinetics.
    Harrison GG
    Br J Anaesth; 1988 Feb; 60(3):279-86. PubMed ID: 3279988
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
    Harrison GG
    S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl)].
    Schulte-Sasse U; Tarnow J; Eberlein HJ
    Anaesthesist; 1982 May; 31(5):241-4. PubMed ID: 6896607
    [No Abstract]   [Full Text] [Related]  

  • 50. [Present-day views on the diagnosis of intraoperative malignant hyperthermia syndrome].
    Mayzner-Zawadzka E; Krawczyńska-Wichrzycka R; Kwiatkowski H; Kamiński B
    Pol Tyg Lek; 1977 Oct; 32(43):1683-6. PubMed ID: 917912
    [No Abstract]   [Full Text] [Related]  

  • 51. Dantrolene sodium in the treatment of malignant hypertension.
    Harrison GG; Chapman DC
    S Afr Med J; 1982 Oct; 62(15):503-4. PubMed ID: 7123413
    [No Abstract]   [Full Text] [Related]  

  • 52. Dantrolene treatment of malignant hyperthermia.
    Bagshaw RJ; Cox RH; Rosenberg H
    J Am Vet Med Assoc; 1981 May; 178(10):1129. PubMed ID: 7275748
    [No Abstract]   [Full Text] [Related]  

  • 53. A faster way to reconstitute dantrolene sodium for malignant hyperthermia.
    Taskalos I
    AORN J; 1988 Feb; 47(2):600, 602-3. PubMed ID: 3348627
    [No Abstract]   [Full Text] [Related]  

  • 54. [Malignant hyperthermia].
    Solera J; Rallo B
    Med Clin (Barc); 1985 Oct; 85(10):431-2. PubMed ID: 4079503
    [No Abstract]   [Full Text] [Related]  

  • 55. Ryanodex--A New Dantrolene Formulation for Malignant Hyperthermia.
    Med Lett Drugs Ther; 2015 Jul; 57(1472):100. PubMed ID: 26147894
    [No Abstract]   [Full Text] [Related]  

  • 56. Dantrolene in human malignant hyperthermia.
    Kolb ME; Horne ML; Martz R
    Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant hyperthermia and glucose-6-phosphate dehydrogenase deficiency.
    Younker D; DeVore M; Hartlage P
    Anesthesiology; 1984 Jun; 60(6):601-3. PubMed ID: 6731919
    [No Abstract]   [Full Text] [Related]  

  • 58. Drawing up dantrolene for the treatment of malignant hyperthermia: use of a drawing up spike to make the process easier and quicker.
    Storey M; Hardy R; Kelly FE
    Anaesthesia; 2020 Jun; 75(6):835. PubMed ID: 32383516
    [No Abstract]   [Full Text] [Related]  

  • 59. Malignant hyperthermia: are we really prepared?
    Hein HA; Roewer N; Jantzen JP
    Anesthesiology; 1987 Mar; 66(3):448-9. PubMed ID: 3826723
    [No Abstract]   [Full Text] [Related]  

  • 60. Dantrium: the approved drug to control malignant hyperthermia.
    Gever LN
    Nursing; 1980 Jul; 10(7):62. PubMed ID: 6900937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.